| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
3T3-L1 preadipocytes differentiate into cells having the biochemical properties of adipocytes; tumour necrosis factor-
(TNF) attenuates this process. Inhibition of differentiation by this cytokine, thought to be mediated at the level of transcription, has been investigated by examining the accumulation of mRNA for six transcription factors and three diversely regulated genes during the first 24 h of the differentiation process. Upon induction of differentiation, a rapid and major accumulation of c-fos and jun-B mRNA, which returned to near basal levels within 4–6 h, was observed. In contrast, c-jun mRNA, although rapidly expressed at the induction of differentiation, remained at relatively constant levels throughout the time-course. Exposure of the cells to 5 nM TNF potentiated the accumulation of all three mRNAs but most significantly that of c-jun (12-fold), which remained elevated for at least 24 h after treatment. In control differentiating cells, krox-20 and fos-B were expressed transiently from 30 min to 2 h, while fra-1 mRNA accumulated over an extended period of 1 to 8 h. Again, TNF enhanced the accumulation of these mRNAs. Accumulation of mRNA for C/EBP, a transcription factor proposed to control the expression of genes involved in the terminally differentiated state, was attenuated after exposure of the cells to TNF. Interleukin-6 (IL-6) mRNA was expressed briefly (30 min to 2 h) and again transiently (at 8 h after induction of differentiation). TNF treatment markedly enhanced accumulation of IL-6 message. We propose that an increased cellular content of one or more transcription factors or the suppression of C/EBP may be responsible for the attenuation of differentiation induced by exposure of the cells to TNF.
This article has been cited by other articles:
|
|
 |
|
  L. E. Bernstein, J. Berry, S. Kim, B. Canavan, and S. K. Grinspoon Effects of Etanercept in Patients With the Metabolic Syndrome. Arch Intern Med, April 24, 2006; 166(8): 902 - 908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. F. Escobar-Morreale, J. I. Botella-Carretero, G. Villuendas, J. Sancho, and J. L. San Millan Serum Interleukin-18 Concentrations Are Increased in the Polycystic Ovary Syndrome: Relationship to Insulin Resistance and to Obesity J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 806 - 811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Retnakaran, A. J. G. Hanley, N. Raif, P. W. Connelly, M. Sermer, and B. Zinman C-Reactive Protein and Gestational Diabetes: The Central Role of Maternal Obesity J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3507 - 3512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kubaszek, J. Pihlajamaki, V. Komarovski, V. Lindi, J. Lindstrom, J. Eriksson, T. T. Valle, H. Hamalainen, P. Ilanne-Parikka, S. Keinanen-Kiukaanniemi, et al. Promoter Polymorphisms of the TNF-{alpha} (G-308A) and IL-6 (C-174G) Genes Predict the Conversion From Impaired Glucose Tolerance to Type 2 Diabetes: The Finnish Diabetes Prevention Study Diabetes, July 1, 2003; 52(7): 1872 - 1876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Zvonic, P. Cornelius, W. C. Stewart, R. L. Mynatt, and J. M. Stephens The Regulation and Activation of Ciliary Neurotrophic Factor Signaling Proteins in Adipocytes J. Biol. Chem., January 17, 2003; 278(4): 2228 - 2235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ruan, P. D. G. Miles, C. M. Ladd, K. Ross, T. R. Golub, J. M. Olefsky, and H. F. Lodish Profiling Gene Transcription In Vivo Reveals Adipose Tissue as an Immediate Target of Tumor Necrosis Factor-{alpha}: Implications for Insulin Resistance Diabetes, November 1, 2002; 51(11): 3176 - 3188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Esposito, A. Pontillo, M. Ciotola, C. Di Palo, E. Grella, G. Nicoletti, and D. Giugliano Weight Loss Reduces Interleukin-18 Levels in Obese Women J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3864 - 3866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.A. Paniagua, J. Lopez-Miranda, A. Escribano, F.J. Berral, C. Marin, D. Bravo, E. Paz-Rojas, P. Gomez, M. Barcos, J.A. Moreno, et al. Cerivastatin Improves Insulin Sensitivity and Insulin Secretion in Early-State Obese Type 2 Diabetes Diabetes, August 1, 2002; 51(8): 2596 - 2603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.E. Humphries, L.A. Luong, M.S. Ogg, E. Hawe, and G.J. Miller The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men Eur. Heart J., December 2, 2001; 22(24): 2243 - 2252. [Abstract] [PDF]
|
|
|
|
|
|
R. F. Morrison and S. R. Farmer Role of PPARgamma in Regulating a Cascade Expression of Cyclin-dependent Kinase Inhibitors, p18(INK4c) and p21(Waf1/Cip1), during Adipogenesis J. Biol. Chem., June 11, 1999; 274(24): 17088 - 17097. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Yudkin, C. D. A. Stehouwer, J. J. Emeis, and S. W. Coppack C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction : A Potential Role for Cytokines Originating From Adipose Tissue? Arterioscler Thromb Vasc Biol, April 1, 1999; 19(4): 972 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Moitra, M. M. Mason, M. Olive, D. Krylov, O. Gavrilova, B. Marcus-Samuels, L. Feigenbaum, E. Lee, T. Aoyama, M. Eckhaus, et al. Life without white fat: a transgenic mouse Genes & Dev., October 15, 1998; 12(20): 3168 - 3181. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. J. Orlicky, J. G. Lieber, C. L. Morin, and R. M. Evans Synthesis and accumulation of a receptor regulatory protein associated with lipid droplet accumulation in 3T3-L1 cells J. Lipid Res., June 1, 1998; 39(6): 1152 - 1161. [Abstract] [Full Text]
|
|
|
|
|
|
S. K. Fried, D. A. Bunkin, and A. S. Greenberg Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 847 - 850. [Abstract] [Full Text]
|
|
|
|
|
|
V. Mohamed-Ali, S. Goodrick, A. Rawesh, D. R. Katz, J. M. Miles, J. S. Yudkin, S. Klein, and S. W. Coppack Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-{alpha}, in Vivo J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4196 - 4200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ziccardi, F. Nappo, G. Giugliano, K. Esposito, R. Marfella, M. Cioffi, F. D'Andrea, A. M. Molinari, and D. Giugliano Reduction of Inflammatory Cytokine Concentrations and Improvement of Endothelial Functions in Obese Women After Weight Loss Over One Year Circulation, February 19, 2002; 105(7): 804 - 809. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
